Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Tocagen Inc (NQ: TOCA)
0.8103 USD  -0.0397 (-4.67%)
Official Closing Price  /  Updated: 4:12 PM EDT, Sep 19, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,224,200
Open 0.8300
Bid (Size) 0.7900 (5)
Ask (Size) 0.8900 (6)
Prev. Close 0.8500
Today's Range 0.7820 - 0.8550
52wk Range 0.7300 - 15.80
Shares Outstanding 19,912,983
Dividend Yield N/A
Performance
YTD
-90.48%
-90.48%
1 Month
-82.91%
-82.91%
3 Month
-86.58%
-86.58%
6 Month
-92.64%
-92.64%
1 Year
-93.34%
-93.34%
Top News
More News
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
Management to host conference call today at 8:30 a.m. Eastern Read More
from PR Newswire
US STOCKS-Wall Street ends higher on trade, ECB stimulus hopes
Wall Street advanced on Thursday, and the S&P 500 ended the session within striking distance of its all-time closing high, buoyed by positive developments on the U.S.-China trade front and a promise of... Read More
category companyNews
from Reuters: Company News
More News
Read More
US STOCKS-Wall Street advances on trade concessions, euro zone stimulus
category companyNews
from Reuters: Company News
Mid-Afternoon Market Update: Dow Rises 150 Points; Tailored Brands Shares Tumble
category SINT , TXG , Mid/Afternoon Market Update , and 16 more.
from Benzinga
Mid-Day Market Update: Tocagen Falls On Failed Late-Stage Brain Cancer Study; Sintx Technologies Shares Jump
category YI , Benzinga , Global , and 16 more.
from Benzinga
UPDATE 2-Tocagen's brain cancer treatment fails late-stage study, shares crash
category companyNews
from Reuters: Company News
Mid-Morning Market Update: Markets Open Higher; Kroger Posts Mixed Q2 Results
category Market News , Eurozone , SINT , and 16 more.
from Benzinga
Tocagen Shares Plummet On Failed Late-Stage Brain Cancer Study
category Trading Ideas , Benzinga , Biotech , and 5 more.
from Benzinga
UPDATE 1-Tocagen's brain cancer treatment fails late-stage study, shares slump
category companyNews
from Reuters: Company News
Tocagen's brain cancer treatment fails late-stage study
category companyNews
from Reuters: Company News
22 Healthcare Stocks Moving In Monday's Pre-Market Session
category VTVT , Health Care , DRAD , and 32 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.